hydroxyindoleacetic acid has been researched along with Adenoma, beta-Cell in 2 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Toole, D | 1 |
Grossman, A | 1 |
Gross, D | 1 |
Delle Fave, G | 1 |
Barkmanova, J | 1 |
O'Connor, J | 1 |
Pape, UF | 1 |
Plöckinger, U | 1 |
Blanchin, M | 1 |
James-Deidier, A | 1 |
Chaumet-Riffaud, PD | 1 |
Chayvialle, JA | 1 |
1 trial available for hydroxyindoleacetic acid and Adenoma, beta-Cell
Article | Year |
---|---|
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Female; France; Gastrinoma; Glucagonoma; Humans; Hydroxyindoleacetic | 1992 |
1 other study available for hydroxyindoleacetic acid and Adenoma, beta-Cell
Article | Year |
---|---|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
Topics: Biomarkers; Chromogranin A; Fasting; Gastrinoma; Humans; Hydroxyindoleacetic Acid; Hypoglycemia; Ins | 2009 |